BNTXBioNTech SE

$112.54

$83.8952 weeks$119.34

Price

$112.54+1.1%1Y

1M+22%1Y+1.1%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

5/10

Value39

Quality80

Momentum38

Growth16

Strongest Quality, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a global next-generation immunotherapy company aiming to pioneer novel medicines against cancer, infectious diseases and other serious diseases. Since our founding in 2008, we have focused on harnessing the power of the immune system to address human diseases with unmet medical needs and major global health burdens.

In the company’s own words · 20-F filed Mar 10, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$22.98B

1Y Return+1.1%

5Y Return-66%

For the full year FY2025, revenue was €2.87B (+4.3% year on year) and net income −€1.14B.